Who is sponsoring NCT05932927?

NCT05932927 is sponsored by Sun Jie.

What condition does NCT05932927 study?

NCT05932927 studies Hepatopulmonary Syndrome (HPS).

What drugs are being tested in NCT05932927?

Interventions: Proteomic sequencing.

What is the status of NCT05932927?

NCT05932927 is currently UNKNOWN.

Last reviewed 2023-07-06 · How we verify

Analysis of Clinical Features of Chronic Liver Disease Complicated With Hepatopulmonary Syndrome

NCT05932927 UNKNOWN

Hepatopulmonary syndrome (HPS) has unknown pathogenesis, limited treatment and poor prognosis. The onset of HPS is insidious and easy to be ignored. Many liver diseases such as "cirrhosis and related complications" are the core characteristics of Beijing You 'an Hospital, but the clinical characteristics of HPS patients in the center are still unclear. The investigators plan to make the diagnosis of HPS among chronic liver disease patients in the hospital according to the diagnostic criteria of HPS proposed in the Practice Guidelines of the International Society of Liver Transplantation in 2016, collect clinical data of HPS participants, evaluate the severity, analyze and summarize clinical characteristics, and conduct management and follow-up. At the same time, The investigators collect blood samples for proteomics tests. In order to improve the diagnosis and treatment level of HPS.

Details

Lead sponsor	Sun Jie
Status	UNKNOWN
Enrolment	500
Start date	Sat Apr 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Sat Jun 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Hepatopulmonary Syndrome (HPS)

Interventions

Proteomic sequencing

Countries

China